Hemostatic Agents Market By Product Type (Combination, Passive Agents and Active Agents) and Therapeutic Area (Plastic Surgery, Cardiology, Orthopedic, General Surgery, Neurology, ObGyn, Oncology and Other Therapeutic Areas) - Global Industry Analysis And Forecast To 2025

Industry Outlook

The hemostatic agents, for example, Hemcon, QuikClot and Celox are intended to advance fast blood coagulation in the cases of the traumatic injury including the bleeding of arteries. The hemostatic bandage items are currently broadly accessible to the EMS experts and people on call, and affirmed for all the dimensions of preparing in a few regions. These items have spared numerous lives in the combat zone and are presently additionally being utilized to stop the bleeding due wound in the work environment, engine vehicle, and at the home mishaps. Therefore, the Hemostatic Agents Market is anticipated to expand and has tremendous scope during the forecast period. The global Hemostatic Agents Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

By Type the market is segmented into Combination, Passive Agents and Active Agents. The Active Agents section is leading the market owing to the enhanced efficiency due to the thrombin based hemostats present.

By Application the market is segmented into Plastic Surgery, Cardiology, Orthopedic, General Surgery, Neurology, ObGyn, Oncology and Other Therapeutic Areas. The Cardiology & General Surgery sections are leading the market due to rising number of cases related to various therapeutic sectors.

Regional Insights

The North American region is leading the global Hemostatic Agents Market owing to factor like; increase in the aged population in this region, increasing number of surgical procedures, increasing number of patient count and other factors.

Hemostatic Agents Market, By Region




North America


U.S.
Canada
Mexico

Europe


Germany
UK
France
Russia
Italy
Rest of Europe

Asia-Pacific


China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific

South America


Brazil
Argentina
Columbia
Rest of South America

Middle East and Africa


Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA


Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.


GELITA AG
Baxter
Advanced Medical Solutions Group plc
Ethicon US, LLC.
Integra LifeSciences
C. R. Bard Inc.
B. Braun Melsungen AG
CryoLife Inc.
Pfizer Inc.
Z-Medica LLC.


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?